Revive Therapeutics Submits Cannabinoid Delivery Technology Findings Abstract for 29th …

TORONTO, Jan. 31, 2018 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (TSX VENTURE:RVV) (OTCQB:RVVTF), a company focused on the research, development and commercialization of novel cannabinoid solutions, today announced that it has submitted an abstract …

Read More

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.